enzymelink
immunosorb
assay
elisa
rapid
immunochromatograph
test
detect
immunoglobulin
g
igg
antibodi
sever
acut
respiratori
syndrom
sar
patient
develop
util
wellcharacter
recombin
protein
gstn
elisa
detect
igg
antibodi
sarscov
convalescentphas
sampl
sar
patient
weakli
crossreact
control
sera
healthi
donor
find
thu
led
kit
sensit
specif
accuraci
respect
test
thu
provid
posit
predict
valu
ppv
neg
predict
valu
npv
addit
elisa
gave
posit
delta
neg
delta
indic
excel
differenti
posit
neg
recombin
protein
also
appli
newli
develop
platform
develop
rapid
test
result
rapid
test
excel
agreement
kappa
valu
elisa
rapid
test
abl
detect
sampl
test
n
maintain
specif
n
ppv
npv
rapid
test
thu
reach
respect
sever
acut
respiratori
syndrom
sar
newli
emerg
diseas
global
signific
highli
contagi
natur
increasingli
global
world
promptli
recogn
world
health
organ
sar
epidem
spread
beyond
place
origin
guangdong
provinc
china
global
alert
declar
first
time
histori
outbreak
affect
peopl
spread
countri
region
short
period
month
mortal
rate
summari
report
avail
http
obvious
diseas
limit
problem
one
profound
consequ
affect
sector
beyond
public
health
care
although
understood
novel
coronaviru
sarscov
etiolog
agent
sar
remain
learn
term
detect
diagnos
treat
diseas
prompt
identif
isol
infect
patient
remain
paramount
import
diseas
control
sinc
drug
vaccin
avail
diseas
option
laboratori
detect
initi
diseas
manag
reli
travel
contact
histori
present
symptom
pcr
test
develop
unpreced
speed
avail
detect
specif
rna
sarscov
thu
provid
laboratori
method
diagnosi
sar
base
method
revis
criteria
case
definit
howev
exist
protocol
pcr
without
limit
singapor
experi
show
posit
predict
valu
ppv
provid
pcr
vari
differ
clinic
specimen
use
e
ling
sarsth
singapor
laboratori
experi
present
confer
sar
research
singapor
republ
singapor
june
recent
report
revers
transcriptionpcr
rtpcr
protocol
two
sar
network
laboratori
evalu
find
confirm
similar
shortcom
rtpcr
therefor
exist
pcr
rule
presenc
sar
viru
neg
result
obtain
neither
exclud
possibl
fals
detect
due
laboratori
contamin
meantim
method
involv
indirect
immunofluoresc
assay
ifa
classic
tissu
cultur
viral
isol
electron
microscopi
cell
cultur
diagnosi
either
timeconsum
technic
demand
altern
approach
therefor
critic
effici
manag
diseas
enzymelink
immunosorb
assay
elisa
one
altern
provid
diagnost
inform
complementari
data
provid
pcr
addit
rapid
pointofcar
test
immunochromatograph
test
also
facilit
case
diagnosi
diseas
manag
remot
area
laboratori
facil
readili
avail
studi
abl
demonstr
potenti
two
serolog
test
develop
util
two
recombin
protein
gstn
report
elsewher
gstn
deriv
nucleocapsid
region
wherea
deriv
uniqu
protein
sarscov
studi
result
suggest
two
serolog
test
excel
sensit
could
provid
confirmatori
inform
diagnosi
sar
especi
suspect
case
initi
screen
pcr
neg
recombin
protein
materi
method
use
obtain
recombin
protein
describ
detail
elsewher
briefli
gstn
use
studi
express
gst
fusion
protein
escherichia
coli
purifi
glutathionesepharos
bead
amersham
pharmacia
protein
gstn
deriv
nucleocapsid
sarscov
highli
conserv
motif
amino
acid
found
coronavirus
delet
wherea
uniqu
sarscov
protein
studi
protein
purifi
superdex
column
akta
fast
protein
liquid
chromatographi
fplc
system
amersham
buffer
use
contain
mm
trishcl
ph
mm
nacl
urea
mm
flow
rate
mlmin
fraction
ml
collect
fraction
combin
dialyz
phosphatebuff
salin
pb
overnight
least
three
chang
buffer
serum
specimen
seventyfour
convalescentphas
serum
sampl
collect
sar
patient
admit
tan
tock
seng
hospit
singapor
gener
hospit
ninetyon
control
serum
sampl
obtain
healthli
local
donor
work
institut
molecular
cell
biolog
singapor
republ
singapor
specimen
collect
consent
patient
sampl
collect
day
onset
symptom
addit
sera
healthi
donor
purchas
bioclin
partner
inc
franklin
mass
includ
studi
addit
healthi
control
elisa
gstn
protein
predilut
carbon
buffer
ph
final
concentr
gml
respect
prior
plate
coat
plate
prepar
describ
refer
briefli
polystyren
microtit
plate
immuno
themo
labsystem
franklin
mass
coat
protein
mixtur
volum
l
per
well
incub
overnight
h
room
temperatur
plate
wash
five
time
pbstween
pbst
nonspecif
bind
site
block
l
per
well
trisbas
diluent
h
room
temperatur
plate
wash
anoth
five
time
l
serum
l
trisbas
diluent
contain
bovin
serum
albumin
bsa
skim
milk
powder
ad
subsequ
plate
incub
min
follow
six
wash
pbst
horseradish
peroxidaseconjug
goat
antihuman
immunoglobulin
g
igg
dilut
ad
l
per
well
mixtur
incub
min
plate
wash
six
time
pbst
color
develop
proceed
addit
enzym
substrat
tetramethylbenzidin
tmb
l
per
well
incub
dark
reaction
stop
ad
l
n
hcl
per
well
optic
densiti
od
measur
nm
refer
filter
rapid
immunochromatograph
test
membranebas
immunochromatograph
test
devic
consist
chromatographi
strip
separ
absorb
pad
hous
cassett
describ
previous
chromatographi
strip
prepar
separ
accord
procedur
detail
refer
slight
modif
assembl
devic
briefli
nitrocellulos
membran
averag
pore
size
whatman
ann
arbor
mich
spray
gstn
recombin
antigen
two
separ
line
concentr
mgml
respect
biodot
irvin
calif
spray
machin
membran
dri
min
immers
min
block
buffer
consist
milliq
purifi
water
stabilcoat
surmod
inc
triton
casein
block
membran
dri
min
affix
membran
back
reagentbear
pad
prepar
use
porou
matrix
porou
matrix
spray
goat
antihuman
igg
antibodi
label
colloid
gold
particl
nm
diamet
reagentbear
pad
dri
h
prior
incorpor
devic
chromatograph
card
prepar
affix
triton
porou
matrix
one
end
nitrocellulos
strip
reagentbear
pad
end
membran
back
assembl
cut
strip
approxim
mm
size
assay
devic
assembl
place
absorb
pad
bottom
half
cassett
separ
follow
one
unit
chromatograph
strip
close
top
half
cassett
addit
reagentreleas
wash
buffer
also
prepar
milliq
purifi
water
mm
nah
po
mm
nacl
sodium
dodecyl
sulfat
ph
test
l
undilut
serum
sampl
ad
specimen
window
assay
devic
sampl
allow
migrat
later
cover
part
membran
sampl
reach
indic
view
window
approxim
three
drop
reagentreleas
wash
buffer
ad
buffer
window
releas
colloid
goldlabel
goat
antihuman
igg
antibodi
separ
remov
pull
protrud
end
allow
chromatograph
element
absorb
pad
come
contact
colloid
goldlabel
goat
antihuman
igg
antibodi
allow
migrat
across
chromatograph
strip
complet
result
read
typic
min
view
window
neg
result
indic
appear
control
line
wherea
posit
result
control
line
either
test
line
appear
view
window
fig
statist
analysi
kappa
statist
use
measur
strength
agreement
result
new
rapid
test
new
elisa
kappa
statist
valu
repres
excel
agreement
good
fair
agreement
poor
agreement
respect
data
analysi
elisa
arbitrari
cutoff
valu
select
confirm
delta
valu
could
provid
indic
optim
differenti
posit
neg
popul
test
sampl
dilut
elisa
detect
igg
antibodi
sarscov
n
convalescentphas
sampl
sar
patient
mean
standard
deviat
od
valu
tabl
fig
contrast
initialposit
sampl
found
test
control
sera
healthi
donor
mean
standard
deviat
od
valu
fig
exampl
assembl
rapid
immunochromatograph
test
devic
separ
transpar
tab
remov
assay
posit
left
devic
assay
sampl
patient
right
anoth
assay
sampl
healthi
control
three
line
view
window
posit
sampl
repres
top
bottom
control
gstn
respect
neg
sampl
gener
control
line
guan
et
al
clin
diagn
lab
immunol
p
fig
test
thu
provid
ppv
neg
predict
valu
npv
tabl
addit
elisa
gave
posit
delta
neg
delta
indic
excel
differenti
posit
neg
furthermor
shown
fig
titrat
curv
obtain
seven
sampl
sar
patient
use
new
elisa
reactiv
end
point
found
dilut
rang
differ
sampl
rapid
immunochromatograph
test
test
undilut
sampl
gstn
protein
use
rapid
test
react
igg
antibodi
respect
sera
sar
patient
met
criteria
sar
tabl
thu
overal
detect
rate
new
test
tabl
gstn
protein
rapid
test
found
crossreact
sera
healthi
control
test
therefor
shown
specif
ppv
npv
respect
test
popul
tabl
result
compar
rapid
test
elisa
gave
excel
agreement
kappa
statist
tabl
addit
excel
correl
r
found
reactiv
end
point
rapid
test
dilut
rang
elisa
compar
use
seven
patient
sampl
fig
recent
studi
suggest
potenti
sarscov
nucleocapsid
protein
diagnost
reagent
detect
sar
howev
applic
protein
develop
viabl
diagnost
test
remain
fulli
demonstr
followup
studi
present
provid
result
fill
gap
newli
develop
elisa
studi
util
two
gstn
recombin
protein
abl
detect
sampl
test
result
thu
demonstr
capabl
new
test
detect
igg
antibodi
sarscov
use
convalescentphas
sampl
day
onset
diseas
addit
new
test
found
highli
specif
initi
fals
posit
control
subject
sampl
test
furthermor
reactiv
end
point
obtain
elisa
suggest
satisfactori
sensit
differ
paramet
although
result
obtain
ident
sampl
previou
preliminari
studi
c
wang
sar
diagnost
scientif
regulatori
challeng
workshop
us
food
drug
administr
http
htm
rang
dilut
reactiv
end
point
nevertheless
good
indic
sensit
compar
better
previous
studi
find
suggest
elisa
readi
applic
recombin
protein
gstn
use
elisa
also
appli
rapid
immunochromatograph
test
appli
separ
two
differ
test
marker
intrins
newli
develop
rapid
immunochromatograph
test
could
provid
indic
case
detect
also
detail
mayb
clinic
signific
correl
establish
later
although
biolog
function
uniqu
protein
yet
unravel
recombin
found
serolog
reactiv
uniqu
sarscov
addit
protein
found
case
give
higher
reaction
signal
test
igm
antibodi
sarscov
kind
find
use
protein
rule
prematur
even
though
result
obtain
rapid
test
indic
limit
case
detect
convalescentphas
sampl
includ
studi
nevertheless
alon
detect
fair
proport
patient
sampl
test
studi
rapid
test
use
acutephas
specimen
might
prove
reward
recombinantbas
elisa
rapid
immunochromatograph
test
develop
studi
found
highli
sensit
specif
sampl
test
result
compar
two
test
gave
excel
agreement
kappa
statist
tabl
excel
correl
r
relat
reactiv
end
point
seven
sampl
test
fig
suggest
although
immunochromatograph
test
simpl
rapid
test
need
special
train
use
perform
test
fulli
compat
elisa
valuabl
addit
current
option
combat
sar
especi
area
laboratori
facil
avail
recent
outbreak
singapor
total
number
probabl
case
sar
initi
report
howev
number
final
adjust
reclassif
serolog
test
ifa
confirm
addit
case
suggest
import
serolog
test
necess
retest
especi
sampl
result
initi
neg
pcr
howev
although
antibodi
sarscov
detect
case
acut
phase
diseas
igg
antibodi
believ
reach
peak
valu
around
day
onset
obviou
symptom
therefor
even
though
found
sensit
convalescentphas
sera
test
util
serolog
test
develop
earlier
detect
yet
establish
may
well
limit
aspect
develop
test
includ
capabl
detect
igm
antibodi
warrant
igm
antibodi
believ
appear
much
earlier
reach
peak
valu
around
day
onset
diseas
